SHSAX Holdings Information

SHSAX is a mutual fund with a total of 170 individual holdings. The top holdings are Eli Lilly and Company stock at 11.34%, Johnson & Johnson at 10.22%, AbbVie at 4.11%, Gilead Sciences at 3.96%, and Merck & Co. at 3.55%.

Total Holdings

170

Top 10 Percentage

46.92%

Asset Class

Equity

Fund Category

Health

Assets

6.01B

Forward PE Ratio

19.00

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	11.34%	704,342
2	JNJ	Johnson & Johnson	10.22%	2,688,331
3	ABBV	AbbVie Inc.	4.11%	1,157,700
4	GILD	Gilead Sciences, Inc.	3.96%	1,736,422
5	MRK	Merck & Co., Inc.	3.55%	1,871,806
6	AMGN	Amgen Inc.	3.49%	588,158
7	UNH	UnitedHealth Group Incorporated	3.04%	677,911
8	ISRG	Intuitive Surgical, Inc.	2.46%	319,051
9	ABT	Abbott Laboratories	2.43%	1,361,894
10	DHR	Danaher Corporation	2.31%	716,192
11	TMO	Thermo Fisher Scientific Inc.	2.28%	285,286
12	EW	Edwards Lifesciences Corporation	2.26%	1,710,975
13	VRTX	Vertex Pharmaceuticals Incorporated	2.08%	273,318
14	MDT	Medtronic plc	2.00%	1,336,319
15	SYK	Stryker Corporation	1.98%	333,071
16	TEVA	Teva Pharmaceutical Industries Limited	1.80%	3,475,093
17	COR	Cencora, Inc.	1.51%	265,860
18	BSX	Boston Scientific Corporation	1.51%	1,284,362
19	LON: AZN	AstraZeneca PLC	1.44%	449,772
20	ARGX	argenx SE	1.42%	121,340
21	MCK	McKesson Corporation	1.20%	79,662
22	ROC1.L	Roche Holding AG	1.08%	147,789
23	BIIB	Biogen Inc.	1.07%	364,188
24	ALNY	Alnylam Pharmaceuticals, Inc.	1.06%	207,149
25	REGN	Regeneron Pharmaceuticals, Inc.	1.05%	87,659

Showing 25 of 170 holdings

Subscribe to see the full list

Activate Now

As of Feb 28, 2026